Details of the Drug Reposition

General Information of This Drug (ID: DMK7OHI)

Drug Name
INCAGN01949   DMK7OHI
Drug Type
Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Advanced malignancy DISAB5B8 2A00-2F9Z Phase 2 [1]
Metastatic malignant neoplasm DIS86UK6 2D50-2E09 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02923349) A Phase 1/2, Open-Label, Dose-Escalation, Safety Study of INCAGN01949 in Subjects With Advanced or Metastatic Solid Tumors. U.S. National Institutes of Health.